Dr. Sheela Ali is Vice President of Science and Innovation with Progenesis, Inc., and serves as a Laboratory Director of IVF laboratories. She has been a part of human IVF since 2008. Dr. Ali completed her master's degree in Clinical Embryology and Andrology at the Jones Institute of Eastern Virginia Medical School in 2013 and earned her PhD in Developmental Biology from the University of North Texas in 2018. During her graduate studies, her research focus was on E-Cadherin and its role in trophectoderm grafts from sibling embryos. The research methodology was built on the foundation of how Artificial Intelligence (AI) and predictive modeling can aid in identification of critical thresholds during IVF treatments. AI application in IVF would allow for efficient real-time support tools in the clinical decisions process for factors such as maximum allowable gonadotropin doses to optimize outcome. Dr. Ali is certified as a High Complexity Laboratory Director (HCLD), Clinical Consultant (CC) and a Technical Supervisor (TS) by the American Board of Bioanalysts (ABB). Throughout her career, she has served as a panelist for NASA's space biology research program as well as worked with the United Nations as an expert reviewer for proposals submitted related to the procurement of PCR testing platforms for SARS-CoV-2. Additionally, she served as a scientific advisory board member for College of Reproductive Biology (CRB) and EmbryVu genetics laboratory and currently serves as a committee member for ASRM membership committee, SART QA committee and CRB committee.